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2SUMMARY
Receptors of the Frizzled family initiate Wnt ligand-dependent signaling controlling
multiple steps in organism development and highly conserved in evolution [1]. 
Misactivation of the Wnt/Frizzled signaling is cancerogenic [2]. Frizzled receptors 
launch several signaling cascades: the canonical pathway regulating -catenin-
dependent transcription [3]; the planar cell polarity pathway polarizing the 
cytoskeleton within the epithelial plane [4]; and the calcium pathway [5]. Frizzled
receptors possess seven transmembrane domains [6] and their signaling depends on 
trimeric G proteins in various organisms [7, 8]. However, Frizzleds constitute a 
distinct group within the G protein-coupled receptors (GPCR) superfamily [9], and 
Frizzled signaling can be G protein-independent in some experimental setups [10, 
11], which led to concerns about the GPCR nature of Frizzled. Here we demonstrate 
that human Frizzled receptors can directly bind the trimeric Go protein in a 
pertussis toxin-sensitive manner. Furthermore, addition of Wnt ligands elicits 
Frizzled-dependent guanine nucleotide exchange on Go. An excess of secreted 
Frizzled-related protein (a Wnt antagonist) prevents Go activation, as does 
pretreatment of Go with pertussis toxin. These experiments provide a biochemical 
proof of the GPCR activities of Frizzled receptors and establish an in vitro assay to 
monitor Frizzled activation by Wnt ligands, applicable for the high-throughput 
agonist/antagonist screening.
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3RESULTS AND DISCUSSION
G protein-coupled receptors (GPCRs) physically bind to trimeric G proteins. In their 
agonist-activated form, GPCRs catalyze the substitution of GDP for GTP on the G-alpha 
subunit of trimeric G proteins - an event causing dissociation of the trimeric complex into 
the G-GTP and the -heterodimer [12]. Both can activate various downstream 
effectors. Thus, for a formal biochemical proof of the GPCR nature of Frizzled (Fz) 
receptors, their capacity to physically and directly bind the trimeric G proteins must be 
demonstrated, as well as the ability of the Wnt ligands to stimulate Fz-dependent guanine 
nucleotide exchange on these G proteins. Fz receptors have been co-immunoprecipitated 
with Go from cellular lysates [13]. However, other proteins complexed together with 
the Fz-G protein immunoprecipitates [13], raising the possibility that the interaction 
between Fz and Go might have been indirect.
To prove the capacity of Fz to directly interact with trimeric G proteins, we 
expressed the human Fz-1 receptor (hFz1) in E.coli as a recombinant plasma membrane-
directed protein tagged with MBP (maltose-binding protein, Figure 1A). Various GPCRs 
have been expressed in such a manner and showed to be functional [14]. Usage of 
bacteria for recombinant production ensured the absence of components of the Wnt 
pathway or other GPCRs. MBP-hFz1-containing bacterial membrane preparations, but 
not control membranes (expressing MBP alone), could efficiently co-precipitate bovine 
trimeric Go protein in a concentration-dependent manner (Figure 1B). Gi is another 
trimeric G protein, not reported to be involved in Fz signaling in any assay. We tested if 
bovine Gi could bind recombinant hFz1 similarly to Go. Figure 1C shows that certain 
amounts of Gi were indeed associated with hFz1-containing membranes, more than with 
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4control membranes. Both Gi and Go are targets of pertussis toxin (Ptx) which uncouples 
these G proteins from their cognate GPCRs [12]. Ptx ADP-ribosylates the conserved 
cysteine residue in the C-terminal tail of the G subunits, disrupting this important G 
protein-receptor interaction site [12, 15]. To test whether the hFr1-interaction with these 
trimeric G proteins was Ptx-sensitive, we pretreated bovine G proteins with Ptx. Binding 
of the Ptx-treated G proteins to the control vs the hFr1 membranes was simultaneously 
analyzed using the mixture of anti-Gi and anti-Go antibodies as the two G-subunits 
have different mobility on SDS-gels [16] (Figure 1B-D). As shown on Figure 1D, Ptx-
modification of Go completely prevented its ability to interact with hFr1, while the 
binding of Gi was unaffected. We thus conclude that the trimeric G protein Go binds 
hFz1 specifically and in the Ptx-sensitive manner, while binding of Gi to the membranes 
is unspecific.
Upon ligand activation, GPCRs serve as guanine nucleotide-exchange factors, 
catalyzing the exchange of GDP for GTP on the -subunit of the trimeric G protein [12]. 
To prove that Fz receptors possessed this basic feature of GPCRs, we designed an in vitro
assay of monitoring G protein activation upon Wnt-Fz interaction. The assay uses the 
Europium-labeled non-hydrolyzable GTP analog whose binding to the G proteins is 
measured through time-resolved fluorescence [17]. The assay further comprises the Fz-
containing detergent-solubilized bacterial membrane fractions and the bovine Go protein. 
Addition of various Wnt ligands (Wnt3a, Wnt5a, Wnt5b, Wnt7a) induced concentration-
dependent activation of the trimeric Go protein in the presence of hFz1-expressing 
membrane fractions (Figure 2A). The curves on the logarithmic scale were bell-shaped: 
high concentrations of the Wnt ligands started to lose the ability to activate Go. This 
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5feature might originate due to the inhibitory action of the carrier proteins present in the 
Wnt preparations as high concentrations of Wnt ligands also produced a decrease in the 
Go response even in the presence of the control membranes (data not shown). 
Alternatively, this bell-shape response might reflect specific features of the Wnt agonists.
In contrast to the hFz1 membranes, the control bacterial membranes (expressing 
MBP alone) did not respond to Wnts by activation of Go: addition of 0.12g/ml Wnt3a 
produced 98 ± 17% (mean ± sem, n≥3) of the control G protein activation (achieved by
addition of BSA instead of Wnt). Responses of the control membranes to same 
concentration of other Wnts were: Wnt5a - 99 ± 29%; Wnt5b - 92 ± 13%; Wnt7a - 86 ± 
17%. Thus, the recombinant hFz1 receptor could specifically activate the trimeric Go 
protein upon addition of the Wnt ligands. Among the Wnt ligands tested, Wnt3a and 
Wnt5a were most active, while Wnt5b and Wnt7a demonstrated a more modest 
stimulation (Figure 2A). The ability of Wnt3a and Wnt5a to directly bind to the hFz1 
receptor has been previously described [18]. The ca. two-fold stimulation of the Go 
protein by hFz1 in the presence of the Wnt ligands is similar to the stimulation of G 
proteins achieved by other activated GPCRs in cellular membranes or in reconstituted 
systems detected using [35S]-GTPS or Eu-GTP [17, 19, 20].
As the binding of Go to hFz1 was sensitive to the Ptx pretreatment (Figure 1D), 
we analyzed whether the ability of hFz1 to serve as the guanine nucleotide exchange 
factor for Go was Ptx-sensitive. We find that pretreatment of Go with Ptx, but not the 
control treatment, abrogated the ability of this G protein to be activated by Wnt3a-hFz1 
in the in vitro assay (Figure 2B). Thus, both the physical binding and the catalytic 
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6relationship between hFz1 and Go are prevented by Ptx, similarly to the interactions 
between many GPCRs and their cognate trimeric G proteins [12].
Secreted Fz-related proteins (sFRP) serve as antagonists of Wnt/Fz signaling in 
vertebrates [1]. Interestingly, sFRP could function as biphasic regulators of the Wnt-
dependent pathway, stimulating it at low concentrations and inhibiting at high 
concentrations [21]. This peculiarity has been interpreted by the existence of two Wnt-
binding sites on the sFRP; the binding by the high-affinity site would actually stimulate 
Fz activation, while additional binding by the low-affinity site sequestered Wnt from 
interaction with Fz [21, 22]. To test whether sFRP could affect Wnt/Fz interactions in the 
in vitro G protein activation assay, sFRP-2 was added to the assay in increasing amounts. 
We found that equimolar amounts of sFRP-2 significantly stimulated Wnt3a-dependent 
Go activation, while excessive concentrations of sFRP-2 prevented Wnt3a from 
activation of hFz1; sFRP-2 alone was not active (Figure 2C). Thus the in vitro G protein 
activation assay can recapitulate physiological interactions between Wnt, Fz, and sFRP.
To demonstrate that other Fz receptors can directly couple to trimeric G proteins, 
we bacterially expressed human Fz receptors 6 and 7 (hFz6, hFz7). When tested for their 
ability to activate Go upon addition of different ligands in the in vitro G protein 
activation assay, hFz6 activated Go in the presence of Wnt7a and to a lesser extent Wnt5a 
(Figure 3A), while hFz7 was mostly stimulated by Wnt5a (Figure 3B). The results 
obtained with three human Fz receptors (1, 6, and 7) and four Wnt ligands (3a, 5a, 5b, 
and 7a) allow us to compose a table of pair-wise Wnt-Fz activations using Go stimulation 
as the read-out (Figure 3C). Overall, ten different Fz receptors and nineteen Wnt ligands 
are encoded by the human genome (see 
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7http://www.stanford.edu/~rnusse/wntwindow.html). As no extensive investigation into 
the abilities of different Wnt ligands to activate different Fz receptors has been 
performed, our information provides a first step in this direction. Our results also 
demonstrate that several members of the human Fz receptor family are GPCRs by the 
biochemical criteria. Direct coupling to trimeric G protein thus occurs for Fz receptors 
transducing the canonical Wnt/Fz pathway (Fz-1 [18]) as well as the planar polarity (Fz-6 
[23]) and the calcium pathways (Fz-7 [24]).
Our in vitro assay recapitulates genetic and physiological observations, which 
validates it as an invaluable tool to investigate Wnt/Fz interactions. It can also be used as 
a platform to screen chemical libraries for small molecule agonists and antagonists of the 
Wnt-Fz interactions. Given the high-degree involvement – positive or destructive – of the 
Wnt/Fz signaling in such medically important processes as cancerogenesis [2], tissue 
regeneration [25], stem cell proliferation [26], neurodegeneration [27] and ageing [28], 
the agonists and antagonists of Wnt/Fz interactions might be of a highest potential 
importance. Such a platform would be directed to detect the highly desired agents acting 
directly at the level of the Wnt ligand-Fz receptor interaction [29].
Fz receptors contain seven transmembrane domains, an extracellular N-terminus, 
and an intracellular C-terminus [6, 30] - typical features of a G protein-coupled receptor 
(GPCR). Indeed, the Fz family of receptors has been placed into a separate group of the
GPCR superfamily [9]. In many experimental setups the Fz signaling pathways have 
been found dependent on trimeric G proteins [7, 8]. For example, reconstruction of the 
canonical pathway in cell culture shows dependence on the Go and Gq signaling [13, 
31], while the calcium pathway in Zebrafish and cellular assays depends on the Go class 
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8of trimeric G proteins [32, 33]. Similarly, experiments on Drosophila demonstrate a 
critical role for Go in transduction of both the canonical and planar cell polarity 
pathways of Fz receptors [34-36]. A role for Go for the cell polarity-like signaling in 
the cell culture has also been demonstrated [37].
However, in certain experimental setups no function for the trimeric G proteins in 
Fz signaling has been detected [10, 11]. This has led to a skepticism in the field of 
Wnt/Fz signaling about the role of trimeric G proteins; it has been maintained that 
without the biochemical proof of the GPCR properties of Fz receptors, the data 
demonstrating an involvement of G proteins in Fz signaling might be due to an indirect 
interaction of the Fz pathways with G proteins.
In the present paper we provide a clear biochemical demonstration of the GPCR 
properties of human Fz receptors. Overall, our data provide the first firm and definitive 
biochemical demonstration that Fz receptors act as typical GPCRs, directly binding 
trimeric G proteins and serving as their guanine nucleotide exchange factors upon 
stimulation with Wnt ligands. Thus our results resolve a long-standing debate over the 
GPCR nature of Fz receptors, initiated by the original demonstration of the GPCR-like 
topology of Fz receptors [6, 30].
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9EXPERIMENTAL PROCEDURES
Materials
Human Fz cDNA clones 4874253 (hFz1), 30340365 (hFz6), and 4549389 (hFz7) were 
from Invitrogen; mouse anti-MBP antibodies was from NEB; functional bovine brain G 
protein (Go plus lower amounts of Gi isoforms, cat. # 371739), rabbit anti-Go and anti-
Gi antibodies (cat. #371726 and PC61), and pertussis toxin A protomer were from 
Calbiochem; the DELFIA™ GTP-Binding kit (including Eu-GTP and AcroWell plates) 
was from Perkin Elmer. Wnt ligands and sFRP-2 (R&D Systems) were reconstituted in 
0.1% BSA in PBS to the following stock concentrations: 40g/ml (Wnt3a), 200g/ml 
(Wnt5a, 5b, and 7a), 400g/ml (sFRP-2) and stored at -80C before use.
Frizzled expression and G protein binding
The pMAL-5HT2c plasmid for bacterial expression of the 5HT2c receptor, modified 
from the pMAL-p2x expression vector (NEB) by the weak Lac promoter [38] was kindly 
provided by Filippo Mancia and Richard Axel. The plasmid was modified by removal of 
the 5HT2c coding sequence and insertion of a multiple cloning site (BamHI-XmaI-KpnI-
SalI-PmlI-BsrGI-MfeI-SacII-XhoI) designed for open reading frame insertion in multiple 
frames. The resulting pMALpoly was used to clone Fz open reading frames lacking the 
predicted signal sequences C-terminally to the MBP sequence.
After bacterial expression and isolation of membranes enriched in Fz receptors following
[38], samples were resolved on SDS-PAGE without boiling. Control membranes were 
obtained using the empty pMALpoly vector expressing MBP alone. Binding of Go to 
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French press-inverted membrane vesicles [39] was performed using 3.5mg/ml membrane 
protein and 10g/ml G proteins.
G protein activation assay and Ptx pretreatment
Membrane fractions were solubilized with 2% n-Dodecyl--D-maltoside (DDM) for 
30min, 4C and centrifuged at 13200g, 10min, 4C, after [40]. In vitro G protein 
activation assay uses the DELFIA™ GTP-binding kit based on the Eu-GTP whose 
binding to G proteins is measured through time-resolved fluorescence [17]. The assay 
reactions contained 15-50g/ml membrane protein, 0.01-0.05% DDM, 0.5g/ml G 
protein, 0.01% BSA, 50mM NaCl, 1mM MgCl2, 50mM Hepes pH 7.4 in the volume of 
100l in 96-well AcroWell plates. After 30min incubation at room temperature on a 
shaker (150 rpm), Eu-GTP was added to 1nM and the incubation was continued for 
30min, followed by filtering and washing as instructed by the manufacturer. Eu-GTP 
retained was measured using the TRF protocol of the Victor3 Multilabel Plate Reader 
(Perkin Elmer). For Ptx (4g/ml) pretreatment, 10g/ml G protein was incubated for 2h 
at 35C in 50mM Tris-HCl pH 8.0, 20mM DTT, 1mM ATP, 20M NAD. Control 
pretreatments excluded Ptx or NAD.
Data for G protein activation upon addition of ligands in the presence of Fz membranes 
are shown on the Figures as % of the control (which is the addition of 0.1% BSA instead 
of Wnt ligands or sFRP-2). Typical raw counts were in the range of 10,000 fluorescence 
units for the non-stimulated G protein activation (e.g. in the presence of Fz membranes 
plus BSA) and in the range of 15,000-25,000 units for the stimulated G protein activation 
(in the presence of Fz membranes plus Wnt ligands).
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FIGURE LEGENDS
Figure 1. Human Frizzled-1 receptor (hFz1) expressed in E.coli can physically bind 
trimeric G proteins.
(A) Membrane fractions of bacteria expressing MBP (maltose binding protein) or the 
MBP-hFz1 fusion probed with anti-MBP antibodies. Two bacterial clones with different 
hFz1 expression levels are shown. The double bands possibly represent different states of 
receptor unfolding by SDS. Total protein amounts loaded on the gel was equal for all 
membrane preparations.
(B) hFz1 membranes, but not control membranes, bind Go. The membranes from (A)
were incubated with bovine Go, followed by ultracentrifugation. The amounts of Go in 
the supernatant (S) and pellet (P) were compared with anti-Go antibodies. Membranes 
with higher hFz1 content bind more Go. Each binding condition on the Fig is done in 
duplicate.
(C) Both control and hFz1 (clone 1) membranes bound bovine Gi.
(D) Binding of Go, but not of Gi, to hFz1 (clone 1) membranes was prevented by 
pertussis toxin (Ptx) treatment but not by the control treatment. All images are 
representatives of multiple (n≥3) experiments.
Figure 2. Wnt ligands can stimulate hFz1-dependent activation of the trimeric G proteins 
in a Ptx- and sFRP-sensitive manner.
(A) Detergent-solubilized hFz1 (clone 1 from Fig 1) stimulated GTP incorporation into 
Go in the presence of different Wnt ligands.
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(B) Wnt3a induced the hFz1-dependent activation of the control-treated Go, but of the 
not Ptx-treated Go.
(C) sFRP-2 in equimolar amounts enhanced, and in excessive amounts inhibited, Wnt3a 
(0.25g/ml)-stimulated hFz1-induced Go activation. All data are shown as mean  sem 
(n from 3 to 10) and represent Go activation by Wnt as the percent of the control (which 
is addition of BSA only). Statistical significance is shown as “*”, “**”, and “***” (P 
value by unpaired t-test <0.05, <0.005, and <0.001, respectively).
Figure 3. Wnt ligands stimulate several Fz receptors to activate the trimeric G proteins.
(A, B) Detergent-solubilized human Fz receptors 6 (A) and 7 (B) stimulated GTP 
incorporation into Go in the presence of different Wnt ligands. The data are presented as 
in Fig 2. 
(C) Summary of the capacity of the tested Wnt ligands to stimulate the tested Fz
receptors to activate Go in vitro. Go activation by the Wnt-Fz pairs is color-coded for two 
parameters: the lowest Wnt concentration showing a significant stimulation, and the 
maximal stimulation achieved by any concentration of Wnt. Control membranes show no 
Go activation in the presence of any Wnt.
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